News | Terumo

December 23, 2020

Corporate

MicroVention, Inc. Files Trade Secret Lawsuit Against Balt USA, LLC

December 09, 2020

Corporate

Holmium-166 SIRT Scout Dose QuiremScout Awarded Top 3 Most Innovative Medical Device in the 2019 Belgian Galenus Prize

December 07, 2020

Corporate

Terumo Aortic Announces Mid-term Results with Real-world Use of The RelayPlus Thoracic Stent Graft System

December 01, 2020

Corporate

Terumo Announces Commercial Launch of the WEB™ in Japan

First and Only Intrasaccular Aneurysm Treatment Device

November 26, 2020

Corporate

Terumo to Increase Its CDMO Production Capacity

Capital Investment in Terumo Yamaguchi D&D for Pre-filled Syringes

November 16, 2020

Corporate

Diabeloop SA. and Terumo Corporation Enter into Joint Development Agreement with Exclusive Distribution Right for DBLG1 Automated Insulin Delivery Solution in Japanese Market

November 10, 2020

Corporate

Coalition Set Up to Find Solutions to the Challenge of Safe, Sustainable and Adequate Blood in Africa

Coalition of Blood for Africa is the first of its kind in the continent

November 09, 2020

Corporate

Terumo Receives CE Mark for MEDISAFE WITH

Japan’s First Patch Pump for Insulin Delivery

November 05, 2020

Financial

Terumo Revises its Full-Year Financial Guidance for FY2020 (PDF 208.83 KB)

October 22, 2020

Corporate

Terumo Creates Global Group Music

September 30, 2020

Corporate

Terumo India Introduces New 'Phygital' Model of Terumo India Skill Lab to Advance Medical and Clinical Skills

September 22, 2020

Corporate

MicroVention-Terumo Announces New Leadership

The Company Appoints New President and CEO

September 21, 2020

Corporate

Terumo Aortic Announces Commercial Launch of TREO Abdominal Stent Graft System in the United States

September 07, 2020

Corporate

Queen Mothers' Workshop to Help Build Community Capacity and Reverse 80% Drop in Blood Collections in Ghana due to COVID-19

September 03, 2020

Corporate

Terumo Joins CD Capital, a China-based Venture Capital Fund, to Discover Novel Technologies in China

August 24, 2020

Corporate

Terumo Cardiovascular and CytoSorbents Collaborate to Commercialize CytoSorb® in Ten U.S. Hotspot States under Emergency Use Authorization for COVID-19

August 06, 2020

Financial

Terumo Announces its Full-Year Financial Guidance for FY2020 (PDF 206.61 KB)

August 05, 2020

Financial

Notice of completion of disposal of treasury shares as Restricted Stock remuneration plan (PDF 65.78 KB)

August 05, 2020

Financial

Notice Concerning the Determination of Details of Issuance of Stock Options (Share Warrants) (PDF 107.72 KB)

August 03, 2020

Corporate

Terumo Announces PRIZER, a New Study Investigating Dual Layer Technology in Patients with FemPop Lesions

August 03, 2020

Corporate

Terumo's PLAJEX™ Enters the US Market by Receiving GMP Certification from FDA to Manufacture Biosimilar Hulio

July 21, 2020

Corporate

Terumo Statement Regarding Media Reports on Japanese Government's Subsidies Project

July 15, 2020

Financial

Notice regarding disposal of treasury shares as Restricted Stock remuneration (PDF 104.02 KB)

July 15, 2020

Financial

Notice Concerning the Issuance of Stock Options (Share Warrants) (PDF 141.77 KB)

July 15, 2020

Corporate

Terumo Acquires Quirem Medical to Enhance its Interventional Oncology Field

June 29, 2020

Corporate

Major Late-breaking Ultimaster DES News from PCR eCourse 2020

Terumo Announces a Major Release of Clinical Outcome Data from Over 37,000 Patients Enrolled in e-ULTIMASTER, the Largest Ever Percutaneous Coronary Intervention (PCI) Registry Reporting Contemporary Drug-eluting Stent Outcomes

June 25, 2020

Corporate

Terumo Announces Voting Results for the Election of Directors (PDF 309.07 KB)

June 09, 2020

Corporate

Terumo Receives the First Certificate under EU-MDR

May 14, 2020

Corporate

Terumo Appoints the Candidates for Directors (PDF 313.28 KB)

May 05, 2020

Corporate

Terumo Aortic Announces US FDA Approval for TREO Endovascular Device

April 29, 2020

Corporate

Terumo Aortic Announces US FDA Breakthrough Device Designation for Thoraflex™ Hybrid Device

April 28, 2020

Corporate

Terumo's BioPearl, the First Biodegradable Drug Eluting Microspheres Received CE mark

April 23, 2020

Corporate

Terumo BCT's Mirasol Reduces the Virus Causing COVID-19 Below the Limit of Detection in Plasma and Platelets

April 22, 2020

Corporate

Terumo Donates USD 2.4 Million in Cash and Products to Support COVID-19 Pandemic Relief Efforts Worldwide

Contributions include USD 1 million to the COVID-19 Solidarity Response Fund for WHO

April 17, 2020

Corporate

Terumo BCT's Mirasol Shows Efficacy Against Virus Causing COVID-19 in Plasma and Platelets

April 10, 2020

Corporate

Terumo BCT and Marker Therapeutics Received the First Device FDA Emergency Use Authorization (EUA) to Treat Acute Respiratory Failure in COVID-19 Patients

April 03, 2020

Corporate

Terumo Statement on COVID-19

March 26, 2020

Corporate

Terumo Group Greenhouse Gas Reduction Target Approved by the SBTi

To Mitigate Climate Change Risks by Science-based Approach

March 23, 2020

Corporate

Terumo Commits to Supporting Australian Bushfire Relief

March 12, 2020

Corporate

Terumo Statement Regarding Production (COVID-19)

March 02, 2020

Corporate

Lancet Oncology Publication Reports Safety and Efficacy of Holmium-166 SIRT after PRRT in Neuroendocrine Tumor Patients

February 26, 2020

Corporate

Terumo Launches New Surgical Sealant AQUABRID® in EMEA Market

Product optimized to stop bleeding during aortic surgical procedures

February 06, 2020

Corporate

Terumo Announces Change of Executive Officers (PDF 195.5 KB)

February 04, 2020

Corporate

Terumo Responds to the Novel Coronavirus Outbreak in China

January 21, 2020

Corporate

Launch of New Terumo-sponsored Randomized Study Investigating Distal Radial Access: DISCO RADIAL

First patient enrolled in the DISCO RADIAL study

January 09, 2020

Corporate

MicroVention Announces FDA Premarket Approval of a New Flow Diverter for the Treatment of Brain Aneurysms

January 08, 2020

Corporate

Terumo Announces Novel Intrasaccular Aneurysm Treatment Device Receives Approval in Japan

The WEB™ is the first intrasaccular flow disruptor approved for the embolization of wide neck bifurcation aneurysms